Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Sofie Lock Johansson, Helle Wulf-Johansson, Anders Schlosser, Ingrid L Titlestad, Bruce Miller, Ruth Tal-Singer, Uffe Holmskov, Jørgen Vestbo, Grith Lykke Sørensen

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstrakt

Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.

OriginalsprogEngelsk
TidsskriftERJ Open Research
Vol/bind5
Udgave nummer2
DOI
StatusUdgivet - apr. 2019
Udgivet eksterntJa

Fingeraftryk Udforsk hvilke forskningsemner 'Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients' indeholder.

Citationsformater